ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
27 Oct 2021

Acarix granted US CPT reimbursement code for CADScor System

Press release (MAR)Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial pan...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
18 Feb 2021

Acarix AB (publ) publicerar Bokslutskommuniké 2020

Press release (MAR) Malmö, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommuniké 2020 Ett starkt avslut p&arin...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Regulatory, Report, Yearend
November 18, 2024
18 Feb 2021

A strong ending of an eventful year

Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful yea...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
26 Nov 2020

FDA identifierar unik kod för CADScor®

Pressmeddelande (MAR) Malmö, 26 november 2020 FDA identifierar unik kod för CADScor® Efter gårdagens meddelande o...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
26 Nov 2020

FDA identifies exclusive code for the CADScor®

Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor® After yesterday’s a...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
25 Nov 2020

Acarix erhåller marknadsgodkännande för CADScor® System för försäljning på den amerikanska marknaden

Pressmeddelande (MAR) Malmö, Sverige, 25 november 2020 Acarix erhåller marknadsgodkännande för CADScor® ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
25 Nov 2020

Acarix receives US market approval for the CADScor® System

Press release (MAR)Malmö, Sweden November 25, 2020 Acarix receives US market approval for the CADScor® System Acarix AB (pu...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
12 Nov 2020

Rättelse: Delårsrapport 2020-01-01 till 2020-09-30

Press release (MAR) Malmö, 12 november, 2020 Rättelse: Delårsrapport 2020-01-01 till 2020-09-30 I den delår...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
12 Nov 2020

Correction: Interim report 2020-01-01 to 2020-09-30

Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Ac...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
12 Nov 2020

A Successful Rights Issue with Focus on Sales!

Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Success...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
12 Nov 2020

En framgångsrik emission med fokus på försäljning!

Press release (MAR) Malmö, 12 november, 2020 Acarix AB (publ) publicerar delårsrapport, januari – september 20...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
09 Sep 2020

Acarix offentliggör preliminärt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 9 september 2020 Acarix offentliggör preliminärt utfall i övertecknad företr&...
Continue reading
  • «
  • ‹
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.